Health Secretary Matt Hancock delivering Downing Street coronavirus press briefing

Health Secretary Matt Hancock delivering Downing Street coronavirus press briefing

Assessment

Interactive Video

Social Studies

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the anticipation of potential annual or biennial vaccine boosters for high-risk groups, emphasizing that no decision has been made yet. It reassures the public about ongoing vigilance and preparation. Public questions address the vaccine rollout for police officers and the possibility of adjusting vaccines for new variants.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the current stance on the need for annual or biennial boosters for high-risk groups?

It has been decided to implement them immediately.

It is a consideration, but no decision has been made yet.

They are deemed unnecessary at this time.

They are only for low-risk groups.

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the primary focus of the current vaccine rollout strategy?

Focusing on rural areas only.

Prioritizing those most at risk, such as the elderly.

Vaccinating all children first.

Vaccinating only healthcare workers.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which group is currently being considered for future vaccine rollout phases?

People with no underlying health conditions.

Individuals living in remote areas.

Only those under 30.

People in high-contact professions.

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is being evaluated regarding the second dose of the vaccine?

If it can be adjusted to work against new variants.

If it should be given to children first.

Whether it can be skipped entirely.

Whether it should be administered monthly.

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a potential future requirement for vaccines mentioned in the discussion?

Vaccines only for those traveling abroad.

Monthly boosters for everyone.

A booster next autumn to combat new variants.

No further doses after the initial two.